Live from the NIH registry
Studies recruiting near Warner Robins right now
Top 25 of 75 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy
Narcolepsy
Phase 2
Interventional 64 participants sought
Sleep Practitioners, LLC — Macon, Georgia (16.9 mi)
· Sponsor: Eisai Inc.
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Type 1 Diabetes Mellitus With Hypoglycemia
Phase 2
Interventional 186 participants sought
East Coast Institute for Research — Macon, Georgia (16.9 mi)
· Sponsor: Zucara Therapeutics Inc.
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
Squamous Cell Carcinoma of Head and Neck
Phase 3
Interventional 500 participants sought
Central Georgia Cancer Care — Macon, Georgia (16.9 mi)
· Sponsor: Janssen Research & Development, LLC
A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM)
Multiple Myeloma
Phase 2
Interventional 200 participants sought
GSK Investigational Site — Macon, Georgia (16.9 mi)
· Sponsor: GlaxoSmithKline
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
Diabetes Mellitus, Type 1
Phase 3
Interventional 150 participants sought
The Jones Center Clinical Research, LLC — Macon, Georgia (16.9 mi)
· Sponsor: vTv Therapeutics
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Phase 3
Interventional 882 participants sought
Gastroenterolgy Associates of Central GA — Macon, Georgia (16.9 mi)
· Sponsor: Janssen Research & Development, LLC
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
Non-Small Cell Lung Cancer
Phase 3
Interventional 1,600 participants sought
Central Georgia Cancer Care — Macon, Georgia (16.9 mi)
· Sponsor: Summit Therapeutics
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
HIV Infections
Phase 2
Interventional 186 participants sought
GSK Investigational Site — Macon, Georgia (16.9 mi)
· Sponsor: ViiV Healthcare
Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)
Pruritus
Phase 3
Interventional 284 participants sought
Skin Care Physicians of Georgia - Macon- Site Number : 8400030 — Macon, Georgia (16.9 mi)
· Sponsor: Sanofi
A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis
Moderate-to-Severe Atopic Dermatitis
Phase 3
Interventional 510 participants sought
Nektar Investigative Site — Macon, Georgia (16.9 mi)
· Sponsor: Nektar Therapeutics
INTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)
Polycythemia Vera
Phase 3
Interventional 250 participants sought
Central Georgia Cancer Care — Macon, Georgia (16.9 mi)
· Sponsor: Ono Pharmaceutical Co., Ltd.
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Diabetes Mellitus, Type 2, Hypertension
Phase 3
Interventional 11,800 participants sought
The Jones Center Clinical Research, LLC — Macon, Georgia (16.9 mi)
· Sponsor: Boehringer Ingelheim
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
Idiopathic Hypersomnia
Phase 3
Interventional 248 participants sought
Sleep Practitioners, LLC — Macon, Georgia (16.9 mi)
· Sponsor: Harmony Biosciences Management, Inc.
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
Untreated Follicular Lymphoma
Phase 3
Interventional 1,018 participants sought
Research Site — Macon, Georgia (16.9 mi)
· Sponsor: AstraZeneca
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
Embryonal Rhabdomyosarcoma, Fusion-Negative Alveolar Rhabdomyosarcoma
Phase 3
Interventional 205 participants sought
Atrium Health Navicent — Macon, Georgia (16.9 mi)
· Sponsor: Children's Oncology Group
Study of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer (LiGeR-CRC1)
Left-sided Colorectal Cancer
Phase 3
Interventional 960 participants sought
Central Georgia Cancer Care - Warner Robins Office — Warner Robins, Georgia (2.0 mi)
· Sponsor: Genmab
A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Idiopathic Hypersomnia
Idiopathic Hypersomnia
Phase 2
Interventional 126 participants sought
Alkermes Investigator Site — Macon, Georgia (16.9 mi)
· Sponsor: Alkermes, Inc.
A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)
Small-cell Lung Cancer, Extensive Stage Small-cell Lung Cancer
Phase 3
Interventional 330 participants sought
Central Georgia Cancer Care PC — Macon, Georgia (16.9 mi)
· Sponsor: Amgen
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Overweight, Obesity
Phase 3
Interventional 1,035 participants sought
The Jones Center Clinical Research — Macon, Georgia (16.9 mi)
· Sponsor: Eli Lilly and Company
Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease
Graves' Disease
Phase 2
Interventional 232 participants sought
Site 118 — Macon, Georgia (16.9 mi)
· Sponsor: Yarrow Bioscience, Inc.
Project: Every Child for Younger Patients With Cancer
Adrenal Gland Pheochromocytoma, Carcinoma In Situ
N/A
Observational 75,000 participants sought
Atrium Health Navicent — Macon, Georgia (16.9 mi)
· Sponsor: Children's Oncology Group
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
Cardiovascular Disease
Phase 3
Interventional 15,100 participants sought
Research Site — Macon, Georgia (16.9 mi)
· Sponsor: AstraZeneca
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
High Risk Cardiovascular Disease, Hypertension
Phase 3
Interventional 11,000 participants sought
Clinical Trial Site — Macon, Georgia (16.9 mi)
· Sponsor: Alnylam Pharmaceuticals
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
EDS, Cataplexy
Phase 3
Interventional 258 participants sought
Sleep Practitioners, LLC — Macon, Georgia (16.9 mi)
· Sponsor: Harmony Biosciences Management, Inc.
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Crohn Disease
Phase 3
Interventional 530 participants sought
Gastroenterology Associates of Central GA — Macon, Georgia (16.9 mi)
· Sponsor: Janssen Research & Development, LLC